LABCORP HOLDINGS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
LABCORP HOLDINGS INC. (LH) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $1.40 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-02-24
- LABCORP HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2017-03-31 was $34.80M, a 1.97% decline year-over-year.
- LABCORP HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2016-03-31 was $35.50M, a 15.88% decline year-over-year.
- LABCORP HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2015-03-31 was $42.20M, a 31.46% increase year-over-year.
- LABCORP HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2014-03-31 was $32.10M.
- LABCORP HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $1.40M, a 12.50% decline from fiscal 2024.
- LABCORP HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $1.60M, a 128.57% increase from fiscal 2023.
- LABCORP HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $700.00K, a 91.46% decline from fiscal 2022.
- LABCORP HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $8.20M, a 38.81% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|
| 2025-12-31 | $1.40M 10-K · filed 2026-02-24 | |
| 2024-12-31 | $1.60M 10-K · filed 2026-02-24 | |
| 2023-12-31 | $700.00K 10-K · filed 2026-02-24 | |
| 2022-12-31 | $8.20M 10-K · filed 2025-02-25 | |
| 2021-12-31 | $13.40M 10-K · filed 2024-02-26 | |
| 2020-12-31 | $18.50M 10-K · filed 2023-02-28 | |
| 2019-12-31 | $24.50M 10-K · filed 2022-02-25 | |
| 2018-12-31 | $44.10M 10-K · filed 2021-02-25 | |
| 2017-12-31 | $34.80M 10-K · filed 2020-02-28 | |
| 2017-03-31 | $34.80M 10-K · filed 2019-02-28 | |
| 2016-12-31 | $35.50M 10-K · filed 2017-02-27 | |
| 2016-03-31 | $35.50M 10-K · filed 2019-02-28 | |
| 2015-12-31 | $42.20M 10-K · filed 2017-02-27 | |
| 2015-03-31 | $42.20M 10-K · filed 2018-02-27 | |
| 2014-12-31 | $32.10M 10-K · filed 2016-03-01 | |
| 2014-03-31 | $32.10M 10-K · filed 2017-02-27 | |
| 2013-12-31 | $55.40M 10-K · filed 2016-03-01 | |
| 2012-12-31 | $25.30M 10-K · filed 2015-02-26 | |
| 2011-12-31 | $45.50M 10-K · filed 2014-02-25 | |
| 2010-12-31 | $33.40M 10-K · filed 2013-02-26 | |
| 2009-12-31 | $7.00M 10-K · filed 2012-02-24 | |
| 2008-12-31 | $35.50M 10-K/A · filed 2011-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |